Treatment with the β-catenin inhibitor ICG-001 significantly decreased serum IL-6 and TNF-α levels (Figures 3(e) and 3(f)), indicating that β-catenin activation was positively related to inflammation in ALI. The gene discussed is IL6; the disease is acute respiratory distress syndrome.